The store will not work correctly when cookies are disabled.
3-(4-bromophenyl)-8-phenylmethanesulfonyl-1,4,8-triazaspiro[4.5]dec-3-en-2-one
ID: ALA5278742
Max Phase: Preclinical
Molecular Formula: C20H20BrN3O3S
Molecular Weight: 462.37
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1NC2(CCN(S(=O)(=O)Cc3ccccc3)CC2)N=C1c1ccc(Br)cc1
Standard InChI: InChI=1S/C20H20BrN3O3S/c21-17-8-6-16(7-9-17)18-19(25)23-20(22-18)10-12-24(13-11-20)28(26,27)14-15-4-2-1-3-5-15/h1-9H,10-14H2,(H,23,25)
Standard InChI Key: PYOPNNNPMJIIQA-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
-0.4625 -0.8983 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2519 -0.4859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9664 -0.8983 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9664 -1.7234 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.2519 -2.1358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4625 -1.7234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6806 -2.1357 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2.3949 -1.7234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0974 -2.7189 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.0930 -2.8499 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.1767 -1.3107 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.7951 -0.7397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4645 -0.0056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6409 -0.0978 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.5917 -0.9532 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.8769 0.7085 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7017 0.7088 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1121 1.4213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6997 2.1357 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8790 2.1373 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4628 1.4259 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1120 2.8499 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
2.3949 -0.8986 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6806 -0.4860 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6814 0.3361 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3958 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1073 0.3397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1121 -0.4845 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
3 2 1 0
4 3 1 0
5 4 1 0
1 6 1 0
6 5 1 0
4 7 1 0
7 8 1 0
7 9 2 0
7 10 2 0
1 11 1 0
11 12 1 0
12 13 1 0
14 13 2 0
1 14 1 0
12 15 2 0
16 13 1 0
17 16 2 0
18 17 1 0
19 18 2 0
20 19 1 0
16 21 1 0
21 20 2 0
19 22 1 0
8 23 1 0
24 23 2 0
25 24 1 0
26 25 2 0
27 26 1 0
28 27 2 0
23 28 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 462.37 | Molecular Weight (Monoisotopic): 461.0409 | AlogP: 2.69 | #Rotatable Bonds: 4 |
Polar Surface Area: 78.84 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.06 | CX Basic pKa: ┄ | CX LogP: 3.29 | CX LogD: 3.29 |
Aromatic Rings: 2 | Heavy Atoms: 28 | QED Weighted: 0.76 | Np Likeness Score: -1.10 |
References
1. Bhuiyan AI, Choi AH, Ghoshal S, Adiele UA, Dana D, Choi JY, Fath KR, Talele TT, Pathak SK.. (2023) Identification of a novel spirocyclic Nek2 inhibitor using high throughput virtual screening., 88 [PMID:37094724] [10.1016/j.bmcl.2023.129288] |